Drug Trials

Drug Controller General of India(DCGI) has approved Favipiravir in the treatment of COVID-19 under Emergency Use Authorization.

1,51,767 cases have been reported from the country in which 64,426 persons have been cured and the recovery rate is pegged at 42.4%. The fatality rate is 2.86% whereas the world average is…